Blood salvage technology could transform surgery

September 24, 2012
Blood salvage technology could transform surgery
Credit: Shutterstock

Having received approval for sale in Europe and Canada, HemoSep is set to revolutionise the healthcare sector. HemoSep is a revolutionary surgical blood salvage technology which was developed at the University of Strathclyde, Glasgow in the United Kingdom. Its developers believe that it has the potential to radically transform the way major surgery is carried out by reducing blood loss in patients.

The device essentially captures spilled during a patient's and then transfuses it back to the patient. While similar devices exist, HemoSep differs in that it was designed to be extremely compact, widening its usage to trauma situations.

Blood donation and blood stocks are a global concern. According to statistics from the (WHO), 90 % of people who are eligible to donate blood do not, and many are not aware that have a short shelf-life, making regular donations essential in order to secure a constant supply; it is roughly estimated that 2.0-2.5 % of the population must give blood regularly. In the WHO European region, 14 countries are below this threshold, 8 of which are Newly Independent States.

Statistics like these highlight the importance of developing new technologies like HemoSep. The process utilised by the device is known as autotransfusion. What this does is reduce the volume of required as well as the problems associated with transfusion reaction.

Professor Terry Gourlay led the development of the technology at the University's Department of Biomedical Engineering, and commented: 'This is a fantastic example of real collaboration between the University of Strathclyde and the medical device industry to take this device from concept to clinical delivery. The introduction of HemoSep to the medical device field will make a significant difference to people's lives and greatly reduce the cost and risks associated with blood transfusions.

The technology has distinct advantages over traditional techniques which are not only costly but technically challenging and involve the use of a complex centrifuge and pumping apparatus by specialist technicians. 'We expect further developments in the form of a derivative of this technology for use in children undergoing open-heart surgery where the challenges of blood conservation are even more critical.'

Clinical trials were conducted at the University of Kirikkale University Hospital in Ankara, Turkey and the device was used in over 100 open-heart surgery operations. The researchers saw that the HemoSep device significantly reduced the need for blood transfusions, together with preservation of normal clotting mechanisms and a reduction in the inflammatory reaction often encountered after such surgical procedures.

The device consists of a blood bag which employs a chemical sponge technology and a mechanical agitator to concentrate blood sucked from the surgical site or drained from the heart-lung machine after the surgery. The separated cells are then returned to the patient by intravenous transfusion.

Professor Serdar Gunaydin, Head of Cardiac Surgery at the University of Kirikkale where the trials were conducted, said: 'The technology is a real step forward in the field of autotransfusion for cardiac surgery, being highly effective, easy to use and associated with a reduction in the need for donor transfusion and in these patients. In the climate of national blood product shortages and concern for disease transmission and immunosuppression, every effort should be made to optimise blood recovery and reduce allogeneic blood usage.

'The HemoSep technology has produced impressive results, it is the easiest method we have ever used. There is no interference with the ongoing operation and product is ready to use following a very short processing time. It quickly and safely recovers substantial proteins, clotting factors and cell concentrates for all types of cardiac procedures.

'We believe this new technology will be one of the essential components of the routine heart surgery in the near future. We even think this technique may be useful for blood preservation during transplantation, orthopaedics and neurosurgery.'

Professors Gourlay and Gunaydin will present the results of the recent clinical trials at the European Society for Artificial Organs (ESAO) congress in Rostock, Germany in September.

Explore further: New technology to transform blood processing

More information: www.who.int/worldblooddonorday/en/

Related Stories

New technology to transform blood processing

August 21, 2012
A pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing blood loss in patients.

Study examines outcomes of patients who refuse transfusion following cardiac surgery

July 2, 2012
Jehovah's Witness patients who undergo cardiac surgery do not appear to be at increased risk for surgical complications or death when compared to patients who undergo cardiac surgery and receive blood transfusions, according ...

Recommended for you

Children best placed to explain facts of surgery to patients, say experts

December 13, 2017
Getting children to design patient information leaflets may improve patient understanding before they have surgery, finds an article in the Christmas issue of The BMJ.

Drug may help surgical patients stop opioids sooner

December 13, 2017
(HealthDay)—Opioid painkillers after surgery can be the first step toward addiction for some patients. But a common drug might cut the amount of narcotics that patients need, a new study finds.

Burn victim saved by skin grafts from identical twin (Update)

November 23, 2017
A man doomed to die after suffering burns across 95 percent of his body was saved by skin transplants from his identical twin in a world-first operation, French doctors said Thursday.

Is a common shoulder surgery useless?

November 21, 2017
(HealthDay)—New research casts doubt on the true effectiveness of a common type of surgery used to ease shoulder pain.

Study shows electric bandages can fight biofilm infection, antimicrobial resistance

November 6, 2017
Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic ...

Obesity increases incidence, severity, costs of knee dislocations

November 3, 2017
A new study of more than 19,000 knee dislocation cases in the U.S. between 2000 and 2012 provides a painful indication of how the nation's obesity epidemic is changing the risk, severity and cost of a traumatic injury.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.